Study evaluates whether patients with head and neck cancer who have PIK3A gene mutations could benefit from regular aspirin use.
Top news of the day across the health care landscape.
Topical medical grade cannabis ointment found to be safe and tolerable in early trial for skin disease.
The generic drug (Wixela Inhub, Mylan) is indicated to treat patients with asthma and chronic obstructive pulmonary disease, including bronchitis and emphysema.
An FDA-approved genetically modified herpes virus can effectively treat metastatic melanoma when injected into the tumor.
Top news of the day across the health care landscape.
A targeted therapeutic approach shrank tumors caused by medulloblastoma, a deadly form a pediatric brain cancer.

Most Popular

Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.